Related Experiment Videos
Utilization of NMR-derived fragment leads in drug design
Jeffrey R Huth1, Chaohong Sun, Daryl R Sauer
1Abbott Laboratories, Abbott Park, Illinois 60064, USA.
Methods in Enzymology
|April 6, 2005
Summary
Large-scale Nuclear Magnetic Resonance (NMR) screening facilitates novel drug design. Fragment-based approaches identify molecular components early, improving inhibitor potency and guiding chemical synthesis for therapeutic targets.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Drug Discovery
Background:
- Large-scale Nuclear Magnetic Resonance (NMR) screening is a powerful tool for identifying novel inhibitors.
- Fragment-based drug design (FBDD) utilizes small molecular fragments to build high-affinity ligands.
- FBDD strategies are increasingly important in modern drug discovery pipelines.
Purpose of the Study:
- To discuss practical considerations for identifying fragment leads using NMR-based screening.
- To highlight the utility of fragment leads in designing potent therapeutic inhibitors.
- To share lessons learned from over a decade of industry experience in FBDD.
Main Methods:
- NMR-based screening for fragment identification.
- Experimental validation of fragment-target interactions.
- Integration of fragment data into lead optimization and chemical synthesis.
Main Results:
- NMR screening enables the discovery of novel fragment-based inhibitors.
- Early identification of molecular fragments accelerates the drug design process.
- Industry experience provides valuable insights into the practical application of FBDD.
Conclusions:
- Fragment-based strategies, powered by NMR screening, are effective for designing potent inhibitors.
- Practical considerations are crucial for successfully utilizing fragment leads in drug design.
- A decade of industry experience underscores the value and challenges of FBDD.